AstraZeneca and the Pharmaceutical Society of Kenya (PSK) launch Kamba Ya Shanga – a commitment to patients
AstraZeneca (www.AstraZeneca.com) is proud to announce its partnership with the Pharmaceutical Society of Kenya (prostitute). The partnership is part of their shared vision and commitment to work towards a future where all people have access to sustainable health solutions for life changing treatment.
the COVID-19 pandemic and the growing burden of noncommunicable diseases (NCDs) have forced health care actors to explore new ways to improve health systems and stimulate the advancement of health ecosystems that focus on ensuring continuum of care and the Improve patient outcomes while improving the patient experience.
The Kamba Ya Shanga Initiative is a pharmacist-led disease management and referral program that aims to improve patient outcomes for chronic illnesses and bring together all of the key health care players in the patient’s disease management journey. Through the program, patients are uniquely identified by the pharmacist, their chronic disease treatment and medication are monitored, and support is provided to ensure optimal treatment and correct use of the equipment; and be seamlessly referred by the pharmacist to his family doctor in the event that further consultations are required.
Dr. Daniella Munene, CEO the Pharmaceutical Society of Kenya (prostitute) said, “Pharmacists are uniquely positioned to expand the reach of health services by becoming more involved in the management of chronic diseases. From identifying poorly treated or undiagnosed diseases to providing drug therapy management and advice, pharmacists can have a positive impact on therapeutic outcomes in patients taking long-term medications for both communicable and non-communicable diseases.
Barbara Nel, AstraZeneca Country President for African Clusters (South Africa, Sub-Saharan and French-speaking Africa) said, “At AstraZeneca we believe that patient experiences and outcomes are our shared responsibility and that innovation does not happen in isolation. Our pharmacists play a vital role in continuing to care for patients, especially in the current landscape. We look forward to working with prostitute at the introduction of Kamba Ya Shanga, a Swahili term that essentially means “a beautiful pearl necklace”. The pearl necklace represents the link between the patient, the pharmacist and the doctor, changes the ecosystem for patients and enables pharmacies to refer patients to a relevant health care provider and to track their progress and their reaction to medication. “
“By joining forces with prostitute We look forward to creating an even greater positive impact for patients and healthcare professionals, and delivering results beyond what any individual stakeholder can achieve. That is the value of partnerships that focus on the patient. “
Distributed by APO Group on behalf of AstraZeneca.
About the Pharmaceutical Society of Kenya (prostitute):
The Pharmaceutical Society of Kenya (prostitute) is the umbrella organization of pharmacists that was founded to enable pharmacists to use their expertise and safety in patient care. Since its inception prostitute continues to advocate a common standard of professional conduct and code of ethics for its members and advocate for the wellbeing of pharmacists. Please visit www.PSK.or.ke.
AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development and commercialization of prescription drugs, primarily for the treatment of diseases in three therapeutic areas – oncology, cardiovascular, renal and metabolic, and respiratory and immunology. AstraZeneca, based in Cambridge, UK, operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.AstraZeneca.com and follow the company on LinkedIn @AstraZeneca.
AstraZeneca and Pharmaceutical Society of Kenya (prostitute) Introduction of Kamba Ya Shanga – a commitment to patients
Africanews provides its readers with content from the APO Group as a service, but does not edit the articles it has published.